RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Assembly Biosciences Stock

Assembly Biosciences P/S 2024

Assembly Biosciences P/S

2.91

Ticker

ASMB

ISIN

US0453961080

WKN

A117S1

As of Sep 21, 2024, Assembly Biosciences's P/S ratio stood at 2.91, a -60.35% change from the 7.34 P/S ratio recorded in the previous year.

The Assembly Biosciences P/S history

Assembly Biosciences Aktienanalyse

What does Assembly Biosciences do?

Assembly Biosciences Inc is an innovative biotechnology company specializing in the development of new therapies for infectious diseases and gastrointestinal disorders. The company was founded in 2005 and is headquartered in South San Francisco, California. The company's business model focuses on the discovery and development of new drugs for infectious diseases and gastrointestinal disorders, with a goal of establishing a strong pipeline of innovative therapeutics. The company's research activities are divided into two main areas: infectious diseases and gastrointestinal disorders. The company currently has no products on the market but is in the development phase of its pipeline. Assembly Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Assembly Biosciences's P/S Ratio

Assembly Biosciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Assembly Biosciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Assembly Biosciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Assembly Biosciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Assembly Biosciences stock

What is the price-to-earnings ratio of Assembly Biosciences?

The price-earnings ratio of Assembly Biosciences is currently 2.91.

How has the price-earnings ratio of Assembly Biosciences changed compared to last year?

The price-to-earnings ratio of Assembly Biosciences has increased by -60.35% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Assembly Biosciences high compared to other companies?

Yes, the price-to-earnings ratio of Assembly Biosciences is high compared to other companies.

How does an increase in the price-earnings ratio of Assembly Biosciences affect the company?

An increase in the price-earnings ratio of Assembly Biosciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Assembly Biosciences affect the company?

A decrease in the price-earnings ratio of Assembly Biosciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Assembly Biosciences?

Some factors that influence the price-earnings ratio of Assembly Biosciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Assembly Biosciences pay?

Over the past 12 months, Assembly Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Assembly Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Assembly Biosciences?

The current dividend yield of Assembly Biosciences is .

When does Assembly Biosciences pay dividends?

Assembly Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Assembly Biosciences?

Assembly Biosciences paid dividends every year for the past 0 years.

What is the dividend of Assembly Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Assembly Biosciences located?

Assembly Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Assembly Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Assembly Biosciences from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Assembly Biosciences pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Assembly Biosciences in the year 2023?

In the year 2023, Assembly Biosciences distributed 0 USD as dividends.

In which currency does Assembly Biosciences pay out the dividend?

The dividends of Assembly Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Assembly Biosciences

Our stock analysis for Assembly Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Assembly Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.